Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients (Q37413270)

20 August 2017

Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients (English)

1 reference

Ana Cristina Simões E Silva

20 August 2017

7

1 reference

20 August 2017

Walkíria Wingester Vilas-Boas

1

1 reference

20 August 2017

Antônio Ribeiro-Oliveira

2

1 reference

20 August 2017

Renata da Cunha Ribeiro

3

1 reference

20 August 2017

Renata Lúcia Pereira Vieira

4

1 reference

20 August 2017

Jerusa Almeida

5

1 reference

20 August 2017

Ana Paula Nadu

6

1 reference

20 August 2017

Robson Augusto Souza Santos

8

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

World Journal of Gastroenterology

20 August 2017

1 reference

20 August 2017

14

1 reference

20 August 2017

44

1 reference

20 August 2017

6824-6830

1 reference

Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Pathogenesis and treatment of hepatorenal syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

The management of ascites and hyponatremia in cirrhosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Liver fibrosis: a balance of ACEs?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Current management of the complications of portal hypertension: variceal bleeding and ascites.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Liver cirrhosis and arterial hypertension.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Rethinking the renin-angiotensin system and its role in cardiovascular regulation.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Current management of portal hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

MELD and PELD: application of survival models to liver allocation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Transection of the oesophagus for bleeding oesophageal varices

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Total effective vascular compliance in patients with cirrhosis. Effects of propranolol

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)

3 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2773877

Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis

3 December 2018

1 reference

12 December 2020

AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers

1 reference

12 December 2020

Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis

1 reference

12 December 2020

Plasma concentrations of angiotensin metabolites in young male normotensive and mild hypertensive subjects

1 reference

12 December 2020

Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis

1 reference

12 December 2020

β-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.14.6824

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19058308

1 reference